Crystal Broussard, MD
Board Certified in Family Medicine · Specialized Training in Obesity Medicine
Quick Insights
Semaglutide and tirzepatide are prescription GLP-1 receptor agonist medications that research suggests can support significant, sustained weight loss when combined with lifestyle modification under physician supervision. Studies indicate mean weight reductions of roughly 15% to 21% over 72 to 104 weeks at the highest approved doses, with results varying by individual, adherence, and baseline factors. At Harmony Aesthetics Spa, I lead physician-supervised GLP-1 programs with weekly InBody body composition monitoring to help track fat loss while working to preserve lean muscle mass.
Key Takeaways
-
Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related health condition. -
Clinical trials indicate that patients who continue treatment long-term, combined with lifestyle modification, may experience sustained weight reductions in the 15% to 25% range, though individual results vary. -
Physician supervision is essential for safe dose titration, side-effect management, screening for contraindications, and ongoing monitoring. -
Weekly InBody body composition analysis at Harmony is designed to support fat loss while helping protect the lean muscle mass that drives metabolic health.
Why It Matters
Active adults across the greater North Houston area often juggle demanding careers, family responsibilities, and health goals, yet find that diet and exercise alone don’t always produce the metabolic shift they’re working toward. For patients with obesity or weight-related conditions like prediabetes, hypertension, or sleep apnea, physician-supervised GLP-1 therapy can offer a science-backed tool to support meaningful, sustained weight loss. When combined with lifestyle modification and monitored by a physician with advanced training in Obesity Medicine, these medications may help patients move toward results that improve both metabolic health and quality of life.
Weight Loss Injections Near Me: Physician-Supervised GLP-1 Programs in Spring, TX
If you are searching for weight loss injections near me and wondering whether they are safe, effective, and available with true physician oversight, you are asking the right questions. As Crystal Broussard, MD, Board Certified in Family Medicine with Specialized Training in Obesity Medicine, I have spent nearly 20 years caring for patients with obesity and metabolic conditions, and I opened Harmony Aesthetics Spa as a physician-owned practice so that medical weight loss could be delivered with the clinical rigor it deserves.
GLP-1 receptor agonist medications like semaglutide and tirzepatide have reshaped what is possible in obesity medicine. Research published in Nature Medicine shows that semaglutide 2.4 mg once weekly, paired with behavioral therapy, produced a mean body weight reduction of 15.2% at week 104 versus 2.6% with placebo. In this article, I will walk you through how these medications work, what the clinical evidence actually shows, why physician supervision and body composition monitoring matter, and what to expect inside a GLP-1 program at our practice serving Spring and the greater North Houston area.
Important Safety Information
GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumor risk observed in rodent studies; the relevance to humans is not established, and these medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (FDA Wegovy Prescribing Information, 2024). Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild to moderate and diminishing over time, especially with gradual dose titration. These medications are not appropriate for patients with a history of pancreatitis, severe gastroparesis, or certain other gastrointestinal conditions, and pregnancy and breastfeeding are contraindications. Every patient I evaluate receives medical screening, baseline lab work, and ongoing physician supervision.
How GLP-1 Receptor Agonists Support Weight Loss
GLP-1, or glucagon-like peptide-1, is a naturally occurring gut hormone that regulates appetite, slows gastric emptying, and enhances insulin secretion after meals. Semaglutide is a GLP-1 receptor agonist, meaning it mimics and amplifies the body’s own GLP-1 signaling. Tirzepatide goes a step further as a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, activating two complementary metabolic pathways.
Reduced Hunger
Amplified GLP-1 signaling lowers appetite drive between meals
Earlier Satiety
Slower gastric emptying helps patients feel full on smaller portions
Glycemic Control
Enhanced insulin response supports stable blood sugar
Metabolic Signaling
Dual GIP/GLP-1 action (tirzepatide) supports fat utilization
The result is a sustained reduction in caloric intake that, when combined with behavioral therapy, can produce clinically meaningful weight loss. I want to be clear with patients: these are not stimulants or traditional appetite suppressants. They work by mimicking and enhancing metabolic signals your body already uses, which is one reason they feel different from older weight-loss medications and why they require physician guidance rather than over-the-counter access.
What the Clinical Evidence Shows: Semaglutide and Tirzepatide for Weight Management
The research base behind GLP-1 therapy is unusually strong for obesity pharmacotherapy. I recommend these medications only to patients who meet clinical criteria for chronic weight management under physician-supervised medical weight loss, and I walk every patient through the actual numbers so expectations stay grounded.
Semaglutide: Sustained Weight Loss Over Two Years
The STEP 5 trial in Nature Medicine 2022 randomized 304 adults with obesity or overweight plus a weight-related comorbidity to semaglutide 2.4 mg once weekly or placebo, both alongside behavioral intervention. At week 104, the semaglutide group saw a mean body weight reduction of 15.2% versus 2.6% with placebo, and 77.1% of semaglutide participants achieved at least 5% weight loss. Individual results ranged widely, depending on adherence, baseline factors, and lifestyle engagement. Gastrointestinal adverse events were the most common, mostly mild to moderate.
Tirzepatide: Greater Weight Reduction with Dual Receptor Activation
The SURMOUNT-1 trial in the New England Journal of Medicine 2022 studied 2,539 adults without diabetes across tirzepatide 5 mg, 10 mg, and 15 mg doses versus placebo. At week 72, mean weight reductions were 15.0%, 19.5%, and 20.9% across the three doses respectively, compared with 3.1% for placebo. At the 15 mg dose, 57% of participants achieved a reduction of 20% or more. Adverse events were consistent with GLP-1 class effects, primarily gastrointestinal, with most events mild to moderate and concentrated during dose escalation.
Clinical Research Note
SURMOUNT-1 (NEJM 2022, n=2,539): mean weight reduction of 20.9% at 72 weeks with tirzepatide 15 mg vs. 3.1% with placebo; 57% of 15 mg participants achieved ≥20% weight reduction.
Maintaining Weight Loss: The Importance of Continued Treatment
One of the most clinically useful trials in this area is SURMOUNT-4 in JAMA 2024. After a 36-week open-label tirzepatide lead-in that produced a mean 20.9% weight reduction, participants were randomized either to continue tirzepatide or switch to placebo for 52 additional weeks. Those who continued treatment saw an additional 5.5% reduction; those who switched to placebo regained a mean of 14%. Nearly 90% of patients who continued tirzepatide maintained at least 80% of their lead-in weight loss, compared with about 17% of those switched to placebo. The takeaway I share with patients: obesity is a chronic condition, and research suggests long-term treatment is typically needed to maintain long-term results.
Protecting Lean Muscle Mass: Why Body Composition Monitoring Matters
Here is a clinical reality that many telehealth-only programs gloss over. Across GLP-1 receptor agonists, roughly a quarter of total weight lost is lean mass rather than fat, according to a 2024 systematic review and network meta-analysis in Metabolism. Higher-dose semaglutide (2.4 mg) and tirzepatide (15 mg) were the most effective for reducing fat mass but were among the least effective at preserving lean mass.
This is not a reason to avoid these medications. It is a reason to manage treatment carefully. Muscle supports daily calorie burn, balance, strength, and long-term weight maintenance, so losing too much of it can undermine the very metabolic gains you are working toward. At Harmony, every GLP-1 patient has weekly InBody body composition scans so that I can track fat loss against lean-mass change in real time. If I see lean mass trending down too quickly, we adjust: higher protein targets, more resistance training, and often we hold the dose rather than increasing it. Patients cannot take shots home from our clinic precisely because that weekly touchpoint is what lets me protect muscle while guiding fat loss.
Medical Weight Loss in Spring, TX: Why Physician Supervision and Local Access Matter
GLP-1 therapy is a medical treatment for a chronic condition. It is not a cosmetic quick fix, and it should never be handed out the way a vitamin subscription is. I see patients from across the greater North Houston area, including The Woodlands, Tomball, Kingwood, Klein, and Cypress, and many of them come to me after a frustrating experience with remote-only programs that offered medication but little real medical oversight.
With nearly 20 years of clinical experience and advanced training in Obesity Medicine, I am able to manage more complex cases: patients with prediabetes, hypertension, PCOS, hormone changes, or prior gastric surgery. I can adjust dosing for side effects, screen for contraindications before treatment begins, and integrate GLP-1 therapy with other interventions when appropriate. Local access means weekly or biweekly in-person visits at one of our locations for InBody monitoring, medication titration, and behavioral support, without relying on impersonal, one-size-fits-all protocols.
When Is It Time to Talk to Me About Weight Loss Injections?
Patients often ask me whether they are a “good enough” candidate. My answer is that candidacy is clinical, not cosmetic.
Signs It May Be Time to Consider GLP-1 Therapy
BMI of 30 or higher, or 27 or higher with a weight-related condition such as prediabetes, hypertension, high cholesterol, sleep apnea, or PCOS
Diet and exercise efforts that have not produced the metabolic change you are working toward
A preference for a physician-supervised, evidence-based approach rather than a quick-fix program
A willingness to commit to lifestyle modification, lab monitoring, and ongoing follow-up as part of long-term care
If any of those describe you, it is a reasonable time to schedule a consultation. I will review your medical history, discuss prior weight-loss efforts, assess candidacy, order appropriate baseline labs, and design a program tailored to your goals and health profile. Results vary, and I will be honest with you about what is realistic.
What to Expect During Your GLP-1 Weight Loss Program at Harmony Aesthetics Spa
Every program begins with a comprehensive consultation. I take a full medical history, review prior attempts at weight loss, discuss your goals, and identify any conditions that would change the treatment plan. Baseline labs typically include a metabolic panel, thyroid function, A1C, and lipids.
Week 1
Consultation, baseline labs, and InBody scan
Weeks 2–4
Starting dose begins; weekly in-office injection and monitoring
Weeks 5–20
Gradual dose titration under physician supervision to minimize GI side effects
Ongoing
Weekly InBody tracking, nutrition coaching, dose adjustments
Maintenance
Individualized plan based on response, body composition, and long-term goals
If you are a candidate, we start at a low dose and titrate gradually over roughly 16 to 20 weeks to minimize gastrointestinal side effects. Each visit includes an InBody body composition scan, a complimentary Lipo-Plex Plus B12 and lipotropic injection, medication administration, and dedicated time for nutrition coaching and behavioral support. You leave with clear guidance on dosing, protein and nutrition targets, and exercise recommendations. This is not a prescription-only service. The monitoring, education, and individualized adjustments are what make the program safe and effective.
Comparing a Physician-Supervised Program to a Telehealth-Only Model
Not all weight-loss injection programs are structured the same way, and in my experience that difference matters more than most patients realize before they start.
| Element | Physician-Supervised GLP-1 Program at Harmony | Telehealth-Only or Non-Physician Programs |
|---|---|---|
| Prescriber qualifications | Physician with Specialized Training in Obesity Medicine | Nurse practitioner or physician assistant with variable supervision models |
| Body composition monitoring | Weekly InBody scans tracking fat vs. muscle change | Scale weight only, or no in-person monitoring |
| Medication management | Individualized titration and side-effect management by a physician | Standardized dosing protocols with limited in-person adjustment |
| Behavioral support | Integrated nutrition coaching and lifestyle modification each visit | App-based tracking or separate coaching, if offered |
| Continuity of care | Ongoing relationship with the same physician and care team | Variable provider assignment, often telehealth-only contact |
| Local access | In-person visits at our Harmony Aesthetics Spa clinic locations | Remote-only care with medication shipped |
One Patient’s Experience
Real patient voices are often more useful than trial percentages. A recent Google review from a patient who found us through our medical weight-loss program captures why consistent, physician-led care matters.
“I just love this place. The injections are the best. It has changed my life.”
Beyond The Best Care Academy
· Verified Google Review
Individual results may vary.
Reviews like this reflect what I often see when a patient stays engaged with a structured program: better follow-through, fewer side-effect surprises, and sustainable progress.
Conclusion: A Physician-Led Path Forward
Semaglutide and tirzepatide are FDA-approved, evidence-based medications that, when combined with lifestyle modification and careful physician supervision, may support significant and sustained weight loss. The clinical trials are robust, but real-world success depends on individualized care, body composition monitoring, and long-term commitment. Results vary by individual, and outcomes depend on many factors, including adherence, baseline health, and lifestyle.
My approach at Harmony Aesthetics Spa is honest, evidence-based, and built around your life, not a generic protocol. If you are considering GLP-1 therapy and want to understand how it fits with your goals, schedule a consultation at Harmony Aesthetics Spa and let’s talk through it directly. You can also call or text us at (346) 597-1202, and we would love to answer your questions. I serve patients throughout Spring and the greater North Houston area.
Harmony Aesthetics Spa — Spring, TX
Ready to Explore Physician-Supervised GLP-1 Therapy?
Schedule a consultation with Dr. Crystal to build a personalized medical weight-loss plan designed around your health, goals, and life.
Medical Disclaimer
This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Semaglutide and tirzepatide are prescription medications administered under physician supervision as part of individualized care plans at Harmony Aesthetics Spa. Results vary based on individual factors including adherence, baseline health, lifestyle, and treatment response. GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumor risk and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Always consult with a qualified physician before starting any new medical treatment.
Dr. Crystal Broussard, MD
Board-Certified Family Medicine · Specialized Training in Obesity Medicine · Founder & Medical Director, Harmony Aesthetics Spa
Dr. Broussard specializes in physician-supervised medical weight loss and aesthetic medicine, bringing nearly 20 years of clinical experience and personal perspective to every patient’s care plan.
